ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
AtriCure, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 27, 2026
$55.53−0.54 (-0.96%)
Close on Oct 19, 2026
- Market cap
- $2.71B
- P/E (TTM)
- 264.4
- Dividend yield
- –
AtriCure, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $465.43M | $450.43M | $435.37M | $422.62M | $408.76M | $393.72M | $382.82M | $370.00M | $356.24M | $345.60M | $333.54M | $318.67M | 81.7% | +13.9% |
| Total International | $104.19M | $101.73M | $99.16M | $95.69M | $91.19M | $86.36M | $82.49M | $77.57M | $73.71M | $69.00M | $65.70M | $62.06M | 18.3% | +14.3% |
| Europe | $64.44M | $63.37M | $61.49M | $59.18M | $56.23M | $52.72M | $49.87M | $46.59M | $43.59M | $40.42M | $38.47M | $36.19M | 11.3% | +14.6% |
| Other International | $7.58M | $7.35M | $6.94M | $6.69M | $6.31M | $5.75M | $5.24M | $4.64M | $4.12M | $3.18M | $2.71M | $2.05M | 1.3% | +20.1% |
| Asia Pacific | – | – | – | – | – | – | – | – | – | – | – | $23.82M | – | – |
From the segment and revenue-disaggregation notes of AtriCure's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.